Our initial experience with rapid enzymatic debriding agent for burn eschar: Case series from an ABA verified burn center
We reviewed 14 consecutive patients at our ABA-verified burn center who received enzymatic debridement with anacaulase-bcdb (NexoBrid®) from January 2020 to May 2023. These patients, part of the NEXT study, had deep partial or full-thickness burns. We aimed to evaluate NexoBrid’s effect on eschar re...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Burns Open |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468912225000112 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|